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Preeclampsia is a disease which involves hypertension and multisystem, it effects approximately 2 to 
8% of all pregnancies and is a significant cause of maternal and newborn mortality and morbidity. It 
develops in the placenta and its pathogenesis is associated with placental abnormalities. Classical 
immunohistochemical studies on placenta have shown that there is a linear increase in iron storage in 
the placenta in the first half of a normal pregnancy, however, these stocks are decreased in normal 3
rd 
trimester placenta. Iron accumulation in term placentas of preeclamptic and normal pregnancies were 
evaluated in this study. Ferritin immunostaining was observed to be more intense in preeclamptic 
group than in the control group, especially in Hofbauer cells, subtrophoblastic areas of stem villous, 
perivasculer stroma and villous stroma. Statistical analysis of the data was performed using SPSS 
software. Mann Whitney U test was used in the analysis and P values below 0.05 were statistically 
significant. In this study, iron accumulations in normotensif and preeclamptic placentas were 
compared. 
 





Preeclampsia is a systemic disorder associated with the 
placenta. Its etiopathogenesis is still not completely 
defined and there are various hypotheses about its cause 
(Bulmer , 1992 ; Burrows et al., 1994).  
Low placentation plays an important role in the etiology 
of preeclampsia. Placental prefusion deficiency and ab-
normal trophoblast invasion are shown to cause 
preeclampsia (Roberts et al., 2001). Increased frequency 
of preeclampsia in cases of disorder in the formation of 
blocking antibodies against antigenic regions on placenta 
or where these antibodies are insufficient leads to the 
opinion that preeclampsia might be caused by a disorder 
in the immune system. Increased incidence of pre-
eclampsia in cases without immunization in a previous 
pregnancy, such as first pregnancies, or in multiple preg-
nancies, molar pregnancies and in multipar females 
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Endothelial dysfunction is important in pathogenesis of  
preeclampsia (Dietl, 200). Basis of preeclampsia/ 
eclampsia pathophysiology is vasospasm, which creates 
a resistance against blood flow and causes development 
of arterial hypertension. Harmful effect of vasospasm 
itself on vessels is also known. Angiotensin II also causes 
injuries in endothelial cells. All these changes cause 
endothelial cell damage, leading to infusion and accumu-
lation of blood ingredients, including thrombocyte and 
fibrin inside the subendothelial region. Eventually, local 
hypoxia, hemorrhage, necrosis and fibrin accumu-lation 
occurs (Cunningham, 2001). 
Healthy continuation and succesful ending of 
pregnancy necessitates adequate development of pla-
cental circulation. Thrombus formation in placental circu-
lation can cause preeclampsia, intrauterine underdeve-
lopment and intrauterine death (Brenner et al., 1997). 
Studies showed that preeclampsia and eclampsia might 
be hereditary (Cooper and Liston, 1979).  
This study aimed to determine placental iron accumu-
lation in term placentas of preeclamptic and normoten-
sive pregnancies of 36 weeks or above  by  immunohisto- 







MATERIALS AND METHODS 
 
Tissues patient population was composed of pregnant females that 
were registered in Dicle University, Faculty of Medicine, Obstetrics 
and Gynecology Department. Human material of the study was 
approved by Dicle University Faculty of Medicine human 
researches board of ethics. 
Placentas were fixed in 10% neutral formalin immediately after 
birth. Taking morphological attributes of placentas into account, 
approximately 1 x 1 cm tissue samples were collected from fetal 
and maternal sides from four different regions; maternal placenta 
central section (MC), maternal placenta peripheric section (MP), 
fetal placenta central section (FC) and fetal placenta peripheric 
section (FP). Basis of central sampling was the center of placental 
disc and sampling was made from 3 cm away from the center. 




Antibodies and staining procedure 
 
The tissue samples were immediately frozen in liquid nitrogen at -
196°C and were kept in a -30°C deep freze until use. Seven 
micrometer thick serial sections were cut using a cryostat, and 
these sections were mounted on gelation covered microscopic 
slides. After drying at room temperature, the samples were kept in 
humidity free containers with slica gel (Merc,1.01925) until immuno-
reactivity was performed as previously described by Khatun et al. 
(2003). Ferritin antibody (Gene Tex, İnc.GTX Rabbit anti-mouse) 
was used as the primary antibody. Biotimylated goat anti-polyvalent 
(ScyTec laborotories) was used as the secondary antibody. 
Control staining was performed, omitting the primary antibody 






The Statistical Package for Social Scienses (SPSS) 14.0 was the 
software used for statistical calculations. Demographic data, clinical 
findings and maternal blood levels of preeclamptic and normal 
pregnancy groups were statistically compared using Mann Whitney 
U test. Intergroup significancy of villous involvement, percentages 
of preeclamptic and normal pregnancy placentas that were applied 
with ferritin immuno-histo-chemistry by immunoperoxidase method 
were evaluated using Mann Whitney U test (Yildiz et al., 2001). 
Values were presented as “mean ± standard deviation”. In all 





Control group immunohistochemical results 
 
In each of the MC, MP, FC and FP sections of placentas, 
ferritin immunereactivity was observed. Ferritin accumu-
lations showed a homogeneous distribution in all layers 
of maternal and fetal surfaces of the placenta. 
Ferritin accumulation in villous was observed predo-
minantly in syncytial layer, subtrophoblastic region, 





sections, despite some sectional differences in villous en-
dothelial vein and perivascular stroma (Figure 2), pre-
sence of various ferritin intensity was shown (Figure 4). 
In contrast to others, FC sections showed more intense 
ferritin accumulation in villous stroma (Figure 3). Ferritin 
immunereactivity, with some individual differences, was 
found to be weaker in terms of villous staining rates in 
control group MC, MP, FC and FP sections as compared 
to those of preeclamptic group. Staining was not seen in 
negative controls (Figure 5). 
 
 
Preeclampsia group immunohistochemical results 
 
In preeclampsia placentas, Hofbauer cells in higher 
numbers, showed more ferritin immunereactivity than 
those in control placentas. Hofbauer cells were observed 
most in FC sections (Figure 7). In preeclampsia, ferritin 
was seen to increase in central zones of the placenta, 
rather than in peripheric sections. Ferritin accumulation 
was seen most in FC sections (Figure 6), than in the MC 
sections (Figure 7) of preeclampsia group. Ferritin 
immunereactivity in stem villous, similar to terminal villi, 
was seen intensely in subtrophoblastic region, perivas-
cular stroma and villous stroma. The least staining was 
visiualized in MP sections (Figure 8) and FP sections 
(Figure 9), respectively. 
In sections where ferritin accumulation was seen in 
more villi and more intensely, atrophic vill, syncytial knots 
and cytotrophoblast proliferation was also more (Figure 
6). In most sections, villous syncytial layer continuity was 
disturbed and syncytiotrophoblasts were unavailable. 
Major finding accompanying loss of syncytiotrophoblasts 
was cytotrophoblast proliferation and intervillous bridges 
and a labyrinth-like view in preeclamptic sections were 
observed (Figure 6 to 7). While ferritin immunereactivity 
in fetal vascular endothelium was seen in a few sections, 
the negative controls did not show any staining (Figure 
10). 
Ferritin staining of placental villi in MC sections were 
62.00 ± 9.933 in the controls and 78.00 ± 12.60 in the 
preeclampsia group. İn FC sections, they were 48.50 ± 
7.215   in    the   controls   and   87.00   ±   6.366   in   the  
preeclampsia group. As a consequence, a statistically 
significant difference was detected between groups 
(p<0.05). In terms of ferritin immunereactivity in MP and 
FP sections, a statistically significant difference was not 




Statistical analysis of immunohistochemical results 
 
Results of the immunohistochemical staining of the 
groups is given in Table 1 and values of ferritin-staining 
villi are shown in graphıc 1. 






Figure 1. Ferritin immunostaining in the  control group 
maternal placenta central zone. Positive ferritin 
immunereactivity viewed in syncytial layer (black arrow), 
subtrophoblastic region (white arrow), villous stroma (VS) 
and Hofbauer cells.( HC), syncytial knot (STK), syncytial 






Figure 2. Ferritin immunostaining in the control 
group maternal placenta peripheric zone. Ferritin 
immunereactivity of different intensity viewed in 
villous vein endothelium (arrow head) and 







Figure 3. Ferritin immunostaining in the control group 
fetal placenta central zone. Intense ferritin 
immunereactivity viewed in Hofbauer cells (HC) and 






Figure 4. Ferritin immunostaining in the 
control group fetal placenta peripheric zone. 
Ferritin immunereactivity of different intensity 
viewed in syncytial layer (black arrows), 
subtrophoblastic region (white arrows), villous 
stroma (VS) and Hofbauer cells (arrow 






Figure 5. Negative control section of the control 
group maternal placenta peripheric zone. Original 
magnification; 160x. 






Ferritin is a protein that is found as a complex with iron 
and is predominatly present in liver, spleen and bone 
marrow as a major iron source. Previously, ferritin was 
regarded only as a storage protein that transfer circu-
lation by hepatocyte decomposition. However, today it is 
known to be a ferritin pool in the circulation (Kaneshige, 
1981). Many studies in literature have reported increasing 
ferritin levels in preeclampsia with increasing severity and 
the underlying causes are discussed (Gitlin, 1992). 
Raman et al. (1992) did not detect change in liver 
enzymes and hemoconcentration in their study, thus, 
concluding that liver damage and hemodynamic changes 
play minor role in hyperferritinemia, and stressed on the 
possible role of placental ferritin.  
In our study, histologic investigation of control group 
placentas resulted in normal view of villous trophoblastic 
layer, villous stroma and fetal vascular structures, 
whereas most common histologic findings in preeclamptic 
group placentas were increased in villous syncytial knot, 
increased in fetal capillary number-volume and increased 
in fibrinoid accumulation, Hofbauer cells and atrophic villi 
(Figure 6). It is reported that in preeclampsia, many cyto-
kines are secreted from Hofbauer cells that stimulate 
vasculogenesis and angiogenesis (Rinehart et al., 1999; 
Numasaki et al., 2003). 
In our study, Hofbauer cells were found to be in larger 
numbers in preeclamptic sections. Both early and recent 
studies are present in literature supporting this finding 
(Fox, 1967). Seval et al. (2007), showed a correlation 
between number of Hofbauer cells in placental villous 
and number of vascular structures in preeclampsia (Seval 
et al., 2007). Studies showing secretion of IL-71, 
proangiogenic molecule that induces neovascularization 
by Hofbauer cells in term placenta are present (Numasaki 
et al., 2003; Pongcharoen et al., 2007). In the light of 
literature information, increase of number and volume of 
fetal capillary in preeclamptic placentas, along with 
increase in the number of Hofbauer cells, in our study 
was explained by increase of cytokines, especially VEGF 
and IL-17, secreted from Hofbauer cells. 
Transferrin receptors (TfRs) have been shown immuno-
histochemically in both normotensif and preeclampsia, in 
villi syncytiotrophoblasts, fetal vascular endothlial cells 
and amniotic membranes (Khatun et al., 2003). In our 
study also, the presence of ferritin in fetal vascular 
endothelium was shown in some of the preeclamptic 
placenta cross sections (Figure 6). This finding supports 
that TfRs are placed in vascular endothelium. 
Khatun et al. (2003) investigated TfRs immuno-
histochemically in their study on syncytiotrophoblasts in 
normal and atrophic villi in preeclamptic placentas. In that 
study, atrophic villi/total villi ratio in preeclamptic group 
was found to be substantially higher than that in normal  
pregnancy placentas. In correlation, atrophic villi were 





tions in our study (Figure 6). 
Khatun et al. (2003) showed strong positive TfR 
immunereactivity in the syncytitrophoblastic region in 
both normal and atrophic villous in normal pregnancy 
placentas. In preeclamptic placentas, on the other hand, 
very low TfR immunereactivity and very low rate of 
positive cell staining were detected. Immuno-histo-
chemical staining by anti-HCG antibody, performed with 
the control, resulted in strong positive immunestaining in 
syncytiotrophoblastic region of the normal and atrophic 
villous in both preeclampsia and control groups. While 
strong TfR immunereactivity was detected in extravillous 
syncytiotrophoblasts, villous vessel endothelial cells and 
amniotic membranes of decidua, very low staining was 
shown in these regions of the preeclamptic placentas. 
Consequently, decrease in TfR production of syncytio-
trophoblasts in preeclampsia was shown. Babies of 
preeclamptic mothers were also shown to be born an 
average of 6 weeks earlier than the control group. This 
increased prematurity was explained by decrease of the 
placental TfR in preeclampsia (Khatun et al., 2003; Van 
Dijk et al., 1993). 
Increased cellular iron concentration resulting from 
decrease in TfR explains increase in total serum iron and 
ferritin in preeclampsia and increase in cellular iron 
concentration is also seen in placental tissue (Rayman et 
al., 2002). Khatun et al. (2003) described ferritin as the 
most prominent indicator of decrease in TfRs and of 
cellular iron accumulation in preeclampsia . 
In our study, in the cross sections where ferritin 
immunohistochemistry was applied, iron storage was 
determined to be significantly higher in preeclamptic 
group than in the controls. Our findings indicated increas-
ed cellular iron storage in preeclampsia and this resulted 
from decrease in TfR production in syncytiotrophoblasts, 
supporting the study of Khatun et al. (2003). 
Decrease in TfRs also explains increase of serum 
ferritin levels of preeclamptic females. In parallel, only 
hematologic parameter that significantly increased in the 
preeclampsia group was found to be maternal serum 
ferritin in our study. In our study, the control group 
maternal Tf and total iron bending capacity (TIBC) was 
higher and this was concluded to be a physiological 
increase in normal pregnancy. Statistically significant 
lower maternal Tf and TIBC in preeclampsia group is 
regarded as a clear indication that preeclampsia disturbs 
maternal adaptation mechanisms and physiology in 
pregnancy. 
In our study, increased maternal serum ferritin in 
preeclampsia group and higher ferritin immunereactivity 
in preeclampsia group than in the controls, shown by 
placenta immunohistochemistry can be explained in two 
ways: either decrease of TfRs in placental and other tis-
sues, or increase of ferritin as a compensatory mecha-
nism of antioxidant system. Results of literature studies 
on preeclampsia, antioxidant systems, TfRs, ferri-tin and 







Figure 6. Ferritin immunostaining of preeclamptic group 
fetal placenta central zone. Many atrophic villi with 
intense ferritin accumulation, increased syncytial knots 
and cytotrophoblast proliferations were seen. Atrophic 
villous (AV), syncytial knot (STK), cytotrophoblast 





Figure 7. Ferritin immunostaining of preeclamptic group 
maternal placenta central zone. Note cytotrophoblast 
proliferation in villi and immunostaining in Hofbauer cells 






Figure 8. Ferritin immunostaining of preeclamptic 
group maternal placenta peripheric zone. Less intense 
ferritin immunereactivity in FC and MC sections. 
Original magnification; 160x. 






Figure 9. Ferritin immunostaining of preeclamptic 
group fetal placenta peripheric zone. Heterogeneity 
and lower intensity in villi ferritin immunereactivity are 
seen as compared to FC, MC and MP sections. 






Figure 10. Negative control section collected from 
maternal peripheric zone of preeclamptic placenta 




The fact that increase of ferritin accumulation in 
preeclampsia group was higher in the central cross 
sections of the placenta in our study presented a new 
dimension to the fetal and maternal placenta classifi-
cation being taken as a basis in placental researches. 
This situation suggests that placental kinetics, 
transportation, storage and endocrine functions differ in 
central and peripheric sections of the placenta, just as 
they do in fetal and maternal sides of it. Also, the opinion 
arises that central regions of the placenta are affected 
more in preeclampsia. However, further information and 





Placental immunohistochemical studies are important in 
the clarification of preeclampsia etiopathogenesis, and 
further studies with broader scope are  necessary  in  this  
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Graph 1. Histogram showing ferritin-staining villi percentage. MC, Maternal placenta central section; 










Brenner B, Mandel H, Lanır N, Younis J, Rothbart H, Ohel G, 
Blumenfeld Z. (1997). Activated protein C resistance can be 
associated with recurrent fetal loss. Br. J. Haematol. 97: 551-554. 
Bulmer JN (1992). Immune aspects of pathology of the placental bed 
contributing to pregnancy pathology. Balliere’s Clinic.Obstet. and 
Gynaecol. 6: 461-487. 
Burrows TD,  King A,  Loke  YW  (1994).  Expression  of  adhesion  
molecules by endovascular trophoblast and decidual endothelial cells: 
Implications for vascular invasion during implantation. Placenta, 15: 
21-33. 
Cooper DW, Liston WA (1979). Genetic control of severe preeclampsia. 
J. Med. Genet.16: 409. 
Cunningham FG (2001).Hypertensive disorders in pregnancy. 21st 
edition, The McGrow-Hill Companies, USA. 
Dietl J (2000).The pathogenesis of pre-eclampsia: New aspects. J. 
Perinat. Med. 28: 464-471. 
Fox H (1967)The incidence and significance of Hofbauer cells in the 
mature human placenta. J. Pathol. Bacterio. 93: 710-717. 
Gitlin N (1992). Liver disease in pregnancy. 3rd ed, WB Saunders 
Company Ltd, London, 
Kaneshige E (1981). Serum ferritin as an assesment of iron stores and 
other hematologic parameters during pregnancy. Obstet. Gynecol. 
57: 238-241. 
Khatun R, Wu Y, Kanenishi K, Ueno M, Tanaka S, Hata T, Sakamoto H 
(2003). Immunohistochemical study of transferrin receptor expression 
in the placenta of pre-eclamptic pregnancy. Placenta, 24: 870-876. 
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T 
(2003). Interleukin-17 promotes angiogenesis and tumor growth. 
Blood. 101: 2620-27. 
Pongcharoen S, Somran J, Sritippayawan S, Niumsup P, Chanchan P, 
Butkhamchot P, Tatiwat P, Kunngurn S, Searle RF. 
(2007).Interleukin-17 Expression in the human placenta. Placenta, 
28: 59-63. 
Raman L, Pawashe AB, Yasodhara P (1992). Hyperferritinemia in 
pregnancy induced hypertension and eclampsia. J. Postgrad. Med. 
38: 65-67. 
Rayman MP, Barlis J, Evans RW, Redman CW, King LJ  





preeclampsia. Am. J. Obstet. Gynecol.187: 412-418. 
Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale 
EA, Martin JN Jr, Bennett WA (1999). Expression of the placental 
cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is 
increased in preeclampsia. Am. J. Obstet. Gynecol. 181: 915-20. 
Roberts JM, Cooper DW (2001). Pathogenesis and genetics of pre-
eclampsia. Lancet, 357: 53-56. 
Seval Y, Korgun ET, Demir R (2007).Hofbauer cells in early human 
placenta: possible ımplications in vasculogenesis and angiogenesis. 
Placenta, 28: 841-845. 
Van Dijk JP, van der Zande FG, Kroos MJ, Starreveld JS, van Eijk HG 
(1993). Number and affinity of transferin receptors at the placental 
microvillous plasma membrane of the guinea pig: Influence of 
gestational age and degree of transferrin glycan chain complexity. J. 








Yıldız L, Aydın O, Kurt K, Barış S, Karagöz F, Kandemir B (2001). 
Placental iron deposits. The meaning of molar pregnancy and fetal 
abnormalities. The Turki. J. Pathol. 17(1-2): 11-13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
